News Takeda begins new R&D link-up with Molecular Templates Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates.
News BMS snaps up cancer biotech IFM in $2.3bn deal BMS will gain rights to preclinical cancer immunotherapy drugs.
News NICE recommends Celgene pancreatic cancer drug Abraxane finally gets NHS funding following price cut.
News Scottish firm gets EU funding for 'off the shelf' cancer cel... First patients could be treated in 2019.
News Ex-Google exec Jeff Huber steps down as GRAIL CEO Huber takes on new role as vice chairman of Board of Directors.
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
